Douglass Winthrop Advisors LLC acquired a new stake in shares of AMETEK, Inc. (NYSE:AME) in the first quarter, HoldingsChannel.com reports. The fund acquired 2,925 shares of the technology company’s stock, valued at approximately $243,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in AME. Commonwealth Equity Services LLC raised its holdings in AMETEK by 1.1% during the fourth quarter. Commonwealth Equity Services LLC now owns 12,665 shares of the technology company’s stock valued at $857,000 after buying an additional 143 shares in the last quarter. Securian Asset Management Inc raised its holdings in AMETEK by 0.7% during the fourth quarter. Securian Asset Management Inc now owns 23,957 shares of the technology company’s stock valued at $1,622,000 after buying an additional 169 shares in the last quarter. CapWealth Advisors LLC raised its holdings in AMETEK by 0.5% during the fourth quarter. CapWealth Advisors LLC now owns 38,187 shares of the technology company’s stock valued at $2,585,000 after buying an additional 182 shares in the last quarter. IFP Advisors Inc raised its holdings in AMETEK by 76.4% during the fourth quarter. IFP Advisors Inc now owns 441 shares of the technology company’s stock valued at $29,000 after buying an additional 191 shares in the last quarter. Finally, Ballentine Partners LLC raised its holdings in AMETEK by 5.2% during the fourth quarter. Ballentine Partners LLC now owns 3,919 shares of the technology company’s stock valued at $266,000 after buying an additional 194 shares in the last quarter. 85.88% of the stock is owned by hedge funds and other institutional investors.

In other news, VP Thomas M. Montgomery sold 3,536 shares of AMETEK stock in a transaction dated Monday, February 25th. The stock was sold at an average price of $79.95, for a total value of $282,703.20. Following the transaction, the vice president now directly owns 20,191 shares in the company, valued at $1,614,270.45. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Timothy N. Jones sold 5,000 shares of AMETEK stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $82.20, for a total value of $411,000.00. Following the completion of the transaction, the insider now owns 37,177 shares in the company, valued at $3,055,949.40. The disclosure for this sale can be found here. Insiders sold 111,563 shares of company stock worth $8,880,480 over the last quarter. 0.80% of the stock is currently owned by corporate insiders.

Several equities analysts have weighed in on AME shares. Cowen restated a “buy” rating and set a $91.00 target price on shares of AMETEK in a report on Wednesday, December 12th. Morgan Stanley upgraded AMETEK from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $81.00 to $85.00 in a report on Tuesday, December 18th. Royal Bank of Canada restated a “buy” rating and set a $82.00 target price on shares of AMETEK in a report on Wednesday, December 19th. Zacks Investment Research lowered AMETEK from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. Finally, Stephens restated a “buy” rating and set a $79.00 target price on shares of AMETEK in a report on Sunday, January 6th. Twelve equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $86.80.

AMETEK stock opened at $83.55 on Wednesday. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.96 and a current ratio of 1.46. The stock has a market capitalization of $19.25 billion, a PE ratio of 25.40, a price-to-earnings-growth ratio of 2.18 and a beta of 1.21. AMETEK, Inc. has a 52 week low of $63.14 and a 52 week high of $84.74.

AMETEK (NYSE:AME) last posted its quarterly earnings data on Tuesday, February 5th. The technology company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.02. The business had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.26 billion. AMETEK had a return on equity of 17.72% and a net margin of 16.05%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.70 earnings per share. Analysts anticipate that AMETEK, Inc. will post 4.04 EPS for the current year.

AMETEK announced that its board has authorized a share repurchase program on Wednesday, February 13th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the technology company to repurchase up to 2.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were paid a $0.14 dividend. The ex-dividend date was Thursday, March 14th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.67%. AMETEK’s payout ratio is presently 17.02%.

WARNING: This news story was first posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/2925-shares-in-ametek-inc-ame-purchased-by-douglass-winthrop-advisors-llc/2952661.html.

About AMETEK

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices worldwide. The company's Electronic Instruments segment offers advanced instruments for the process, aerospace, power, and industrial markets; process control instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; and instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets.

Recommended Story: Quiet Period Expirations

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.